BioForce Nanosciences Holdings, Inc. BFNH
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 613.70K | 474.20K | 490.00K | 495.40K | 501.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 613.70K | 474.20K | 490.00K | 495.40K | 501.50K |
| Operating Income | -613.70K | -474.20K | -490.00K | -495.40K | -501.50K |
| Income Before Tax | -98.20K | -459.70K | -1.29M | -1.30M | -1.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.10 | -0.46 | -1.29 | -1.30 | -1.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -98.20K | -459.70K | -1.29M | -1.30M | -1.30M |
| EBIT | -613.70K | -474.20K | -490.00K | -495.40K | -501.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | -0.01 | -0.04 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.04 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 134.11M | 134.09M | 132.82M | 128.56M | 124.31M |
| Average Diluted Shares Outstanding | 134.11M | 134.09M | 132.82M | 128.56M | 124.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |